Autopsy report · NCT00680459

Ethanol Locks for the Treatment of Central Venous Line Infections

“inability to enroll adequate number of patients”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 3 years 1 month before it stopped.
• 13 participants enrolled.
• Results were posted on the registry 2 years 9 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Baystate Medical Center

Sponsor type

University, hospital or other

Conditions

Bloodstream Infection

Interventions

70% ethanol; heparin flush solution

Participants

13

Sites

1

Countries

United States

Trials that died the same way

• Tracking of Lipid Lowering Therapy in Jordan
  “Inadequate enrolling numbers of patients” (91% match in meaning)
• Wellness Initiative at New York University
  “Due to inability to enroll patients” (85% match in meaning)
• Azopt (Brinzolamide 1.0%) Plus Travatan (Travoprost 0.004%) in Treating Patients With Chronic Angle-Closure Glaucoma (CACG)
  “difficulty of enrolling patients” (85% match in meaning)
• Intra-erythrocyte Dexamethasone Versus Placebo in Patients With Steroid-dependent Crohn's Disease
  “due to the difficulty to enroll suitable patients” (83% match in meaning)
• Experience of Erlotinib in Patients With Advanced Non-Small Cell Lung Cancer
  “Difficulty in enrolling patients” (83% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.